PSA consent a ‘charade’

Then, when long-awaited US and European screening trial results became available in 2009, rather than provide a clear signal on efficacy, they “created more confusion than clarity” and this remains the case.

In a commentary in the New England Journal of Medicine on the recent US Preventative Services Taskforce (USPSTF) recommendation against PSA screening, experts on clinical decision-making and ethics said although this advice was welcome it was unlikely to end the PSA debate.

“For two decades, primary care physicians have been expected to present a flawed screening

Latest

Trending